271
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Sex hormone levels in drug-naïve, first-episode patients with psychosis

ORCID Icon, , ORCID Icon, , & ORCID Icon
Pages 20-24 | Received 15 May 2019, Accepted 25 Nov 2019, Published online: 11 Dec 2019

References

  • Abel KM, Drake R, Goldstein JM. 2010. Sex differences in schizophrenia. Int Rev Psychiatry. 22:417.
  • Akhondzadeh S, Rezaei F, Larijani B, Nejatisafa AA, Kashani L, Abbasi SH. 2006. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophrenia Res. 84:405.
  • Aleman A, Kahn RS, Selten JP. 2003. Sex differences in the risk of schizophrenia. Arch Gen Psychiatry. 60:565.
  • Bergemann N, Parzer P, Runnebaum B, Resch F, Mundt C. 2007. Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia. Psychol Med. 37:1427.
  • Białek M, Zaremba P, Borowicz KK, Czuczwar SJ. 2004. Neuroprotective role of testosterone in the nervous system. Polish J Pharmacol. 56:509–518.
  • da Silva TL, Ravindran AV. 2015. Contribution of sex hormones to gender differences in schizophrenia: a review. Asian J Psychiatry. 18:2.
  • Ebinger M, Sievers C, Ivan D, Schneider HJ, Stalla GK. 2009. Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression? J Psychopharmacol. 23:841.
  • Fernandez-Egea E, García-Rizo C, Miller B, Parellada E, Justicia A, Bernardo M, Kirkpatrick B. 2011. Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis. Psychosom Med. 73:643.
  • Garcia-Segura LM, Azcoitia I, DonCarlos LL. 2001. Neuroprotection by estradiol. Prog Neurobiol. 63:29.
  • Grossmann M, Tang Fui M, Dupuis P. 2014. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 16:223.
  • Hayes E, Gavrilidis E, Kulkarni J. 2012. The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia. Schizophrenia Res Treatment. 2012:1.
  • Herting MM, Maxwell EC, Irvine C, Nagel BJ. 2012. The impact of sex, puberty, and hormones on white matter microstructure in adolescents. Cerebral Cortex. 22:1979.
  • Huber TJ, Tettenborn C, Leifke E, Emrich HM. 2005. Sex hormones in psychotic men. Psychoneuroendocrinology. 30:111.
  • Ko Y-H, Jung S-W, Joe S-H, Lee C-H, Jung H-G, Jung I-K, Kim S-H, Lee M-S 2007. Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology. 32:385.
  • Ko YH, Lew YM, Jung SW, Joe SH, Lee CH, Jung HG, Lee MS. 2008. Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 28:375.
  • Kulkarni J, De Castella A, Fitzgerald PB, Gurvich CT, Bailey M, Bartholomeusz C, Burger H. 2008. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry. 65:955.
  • Leung A, Chue P. 2000. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl. 401:3–38.
  • Markham JA. 2012. Sex steroids and schizophrenia. Rev Endocr Metab Disord. 13:187.
  • McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. 2004. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2:13.
  • Mendrek A, Mancini-Marïe A. 2016. Sex/gender differences in the brain and cognition in schizophrenia. Neurosci Biobehav Rev. 67:57–78.
  • Riahi F, Izadi-Mazidi M, Ghaffari A, Yousefi E, Khademvatan S. 2016. Comparison of plasma neurosteroid and prolactin levels in patients with schizophrenia and healthy individuals. Scientifica. 2016:1.
  • Riecher-Rössler A, Häfner H, Dütsch-Strobel A, Oster M, Stumbaum M, van Gülick-Bailer M, Löffler W. 1994. Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry. 36:492.
  • Saad F, Gooren L. 2009. The role of testosterone in the metabolic syndrome: a review. J Steroid Biochem Mol Biol. 114:40–43.
  • Shirayama Y, Hashimoto K, Suzuki Y, Higuchi T. 2002. Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophrenia Res. 58:69.
  • Taherianfard M, Shariaty M. 2004. Evaluation of serum steroid hormones in schizophrenic patients. Indian J Med Sci. 58:3–9.
  • Trotman HD, Holtzman CW, Ryan AT, Shapiro DI, MacDonald AN, Goulding SM, Brasfield JL, Walker EF. 2013. The development of psychotic disorders in adolescence: A potential role for hormones. Horm Behav. 64:411.
  • van der Werf M, Hanssen M, Köhler S, Verkaaik M, Verhey FR, van Winkel R, van Os J, Allardyce J. 2014. Systematic review and collaborative recalculation of 133 693 incident cases of schizophrenia. Psychol Med. 44:9.
  • van Rijn S, Aleman A, de Sonneville L, Sprong M, Ziermans T, Schothorst P, van Engeland H, Swaab H. 2011. Neuroendocrine markers of high risk for psychosis: salivary testosterone in adolescent boys with prodromal symptoms. Psychol Med. 41:1815.
  • Vermeulen A, Verdonck L, Kaufman JM. 1999. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 84:3666–3672.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.